Logo image of PESO.CA

PESORAMA INC (PESO.CA) Stock Fundamental Analysis

Canada - TSX-V:PESO - CA7157921072 - Common Stock

0.26 CAD
-0.01 (-3.7%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

1

Overall PESO gets a fundamental rating of 1 out of 10. We evaluated PESO against 0 industry peers in the Unkown industry. PESO has a bad profitability rating. Also its financial health evaluation is rather negative. PESO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PESO has reported negative net income.
PESO had a negative operating cash flow in the past year.
PESO.CA Yearly Net Income VS EBIT VS OCF VS FCFPESO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -2M -4M -6M -8M -10M

1.2 Ratios

Industry RankSector Rank
ROA -36.14%
ROE N/A
ROIC N/A
ROA(3y)-52.81%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PESO.CA Yearly ROA, ROE, ROICPESO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 200 -200 -400

1.3 Margins

PESO's Gross Margin has improved in the last couple of years.
PESO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.7%
GM growth 5YN/A
PESO.CA Yearly Profit, Operating, Gross MarginsPESO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

PESO does not have a ROIC to compare to the WACC, probably because it is not profitable.
PESO has about the same amout of shares outstanding than it did 1 year ago.
PESO has a worse debt/assets ratio than last year.
PESO.CA Yearly Shares OutstandingPESO.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 20M 40M 60M 80M
PESO.CA Yearly Total Debt VS Total AssetsPESO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -1.96, we must say that PESO is in the distress zone and has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.96
ROIC/WACCN/A
WACC7.42%
PESO.CA Yearly LT Debt VS Equity VS FCFPESO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 10M 20M

2.3 Liquidity

PESO has a Current Ratio of 0.53. This is a bad value and indicates that PESO is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.20 indicates that PESO may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.2
PESO.CA Yearly Current Assets VS Current LiabilitesPESO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for PESO have decreased strongly by -25.08% in the last year.
PESO shows a small growth in Revenue. In the last year, the Revenue has grown by 4.94%.
PESO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 35.87% yearly.
EPS 1Y (TTM)-25.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.17%
Revenue 1Y (TTM)4.94%
Revenue growth 3Y35.87%
Revenue growth 5YN/A
Sales Q2Q%12.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PESO.CA Yearly Revenue VS EstimatesPESO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

PESO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PESO.CA Price Earnings VS Forward Price EarningsPESO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PESO.CA Per share dataPESO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 -0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PESO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PESORAMA INC

TSX-V:PESO (10/17/2025, 7:00:00 PM)

0.26

-0.01 (-3.7%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners10.48%
Ins Owner ChangeN/A
Market Cap36.71M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.54
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.17
BVpS-0.06
TBVpS-0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.14%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.8%
FCFM N/A
ROA(3y)-52.81%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.7%
GM growth 5YN/A
F-Score4
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 57.86%
Cap/Sales 7.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.53
Quick Ratio 0.2
Altman-Z -1.96
F-Score4
WACC7.42%
ROIC/WACCN/A
Cap/Depr(3y)31.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.94%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.94%
Revenue growth 3Y35.87%
Revenue growth 5YN/A
Sales Q2Q%12.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y37.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-249.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-216.06%
OCF growth 3YN/A
OCF growth 5YN/A